Teva Gets Actavis Boost, Q4 Results Top Estimates
February 13, 2017 at 08:44 AM EST
Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) reported better-than-expected results for its fourth quarter, driven by the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.